Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Asahi Kasei: Flivas, Toledomin Prop Up Drug Business
June 3, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
June 3, 2002
- All Major Listed Wholesalers Report Increases in Sales
June 3, 2002
- PII Results of Iressa Reported at ASCO
June 3, 2002
- Drug Sales Up 3.5% in FY2001: CR&C
May 27, 2002
- GL on Subarachnoidal Hemorrhage Compiled
May 27, 2002
- AstraZeneca PLC: 1st Qtr Sales Up 13% to US$4,421 Mil.
May 27, 2002
- Otsuka Pharma Factory Sues Shionogi Claiming Infringement of Design Right
May 27, 2002
- Registration for J-WIND Increases Sharply
May 27, 2002
- Acarbose Prevents Type 2 Diabetes: STOP-NIDDM Study
May 27, 2002
- EPS Forms Alliance with VirtualeX for Subject Recruitment
May 27, 2002
- Mental Care Important for Atopic Dermatitis: ARC Seminar
May 27, 2002
- Novartis Opens Biomedical Research Center in US
May 27, 2002
- WEBSITE NEWS
May 27, 2002
- LWC to Undertake Survey on Lower Back Pain
May 27, 2002
- Novartis' Zometa to Be Approved for Bone Metastasis in the EU
May 27, 2002
- Teijin: Drug Sales, Operating Profits Up 6.7%, 7.0%
May 27, 2002
- Drug Terashima Joins AEON Welcia Stores
May 27, 2002
- Bayer AG: 1st Qtr Sales Down 6% to 7 Bil. Euro
May 27, 2002
- Health Minister Asks for Consent to 30% Copayment Hike
May 27, 2002
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…